A Randomized, Double Blind, Multi-Center, Placebo Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Doses Of NT100 Following IVF In Women With A History Of Repeated IVF Failures (Thrive-IVF)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs NT 100 (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms Thrive-IVF
- Sponsors Nora Therapeutics
- 17 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 13 Jun 2013 New trial record